Nektar Therapeutics (NKTR) insider trading.
In Q3 2026, insiders at Nektar Therapeutics reported 8 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $441K.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 3
- Net shares, P minus S
- -6,285
- Insiders
- 7
- Last filed
- 2026-09-25
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Zalevsky Jonathan | Officer · Chief R&D Officer | 2 | 0 | 2 |
| Ajer Jeffrey Robert | Director | 1 | 0 | 0 |
| Brainard Diana | Director | 1 | 0 | 0 |
| Chess Robert | Director | 1 | 0 | 0 |
| Greer R Scott | Director | 1 | 0 | 0 |
| Whitfield Roy A | Director | 1 | 0 | 0 |
| Robin Howard W | Director, Officer · President & CEO | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Ajer Jeffrey Robert | A (A) | 2,000 | $0 | 4,277 | Form 4 |
| 2026-09-23 | Brainard Diana | A (A) | 2,000 | $0 | 3,904 | Form 4 |
| 2026-09-23 | Chess Robert | A (A) | 2,000 | $0 | 19,019 | Form 4 |
| 2026-09-23 | Greer R Scott | A (A) | 2,000 | $0 | 22,239 | Form 4 |
| 2026-09-23 | Whitfield Roy A | A (A) | 2,000 | $0 | 16,417 | Form 4 |
| 2026-08-18 | Robin Howard W | S (D) | 418 | $71.98 | 54,627 | Form 4 |
| 2026-08-18 | Zalevsky Jonathan | S (D) | 186 | $71.98 | 9,570 | Form 4 |
| 2026-06-30 | Zalevsky Jonathan | S (D) | 5,681 | $70 | 9,756 | Form 4 |
Transaction codes in this quarter
Get NKTR insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=906709&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NKTR company page · Nektar Therapeutics on SEC.gov
Questions
Are insiders buying or selling Nektar Therapeutics (NKTR)?
In Q3 2026, insiders at Nektar Therapeutics reported 8 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $441K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Nektar Therapeutics insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nktr.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.